Clinical Trial Update: An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

View source ↗

Summary

An observational study evaluating SYMLIN (pramlintide acetate) injections used in insulin-using patients with Type 1 or Type 2 diabetes; the study completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2009-06-24